Specifically, CBD treatment suppressed the expression of 5-LOX and increased the production of fatty acid amide hydrolase (FAAH), which led to a reduction in anandamide (AEA) synthesis, ultimately inhibiting the viability of glioma cells [25]. Here, FAAH is linked to glioma.